Lv11
40 积分 2024-03-01 加入
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
1小时前
已完结
Effects of Amlodipine on Glomerular Filtration, Growth, and Injury in Experimental Hypertension
14天前
已完结
MAP-2 Expression in the Human Adenohypophysis and in Pituitary Adenomas. An Immunohistochemical Study
22天前
已完结
CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
26天前
已完结
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
26天前
已完结
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats
27天前
已完结
Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
27天前
已完结
Blood Pressure and Kidney Disease Progression in Advanced Chronic Kidney Disease: Findings from the CRIC and KNOW-CKD Studies
30天前
已关闭
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
30天前
已完结
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage
1个月前
已完结
皖公网安备34019202002308
